Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
29.38
-0.62 (-2.07%)
Dec 5, 2025, 4:00 PM EST - Market closed
Beta Bionics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 88.57 | 65.12 | 12 | 0.18 |
| Revenue Growth (YoY) | 67.01% | 442.93% | 6601.12% | - |
| Cost of Revenue | 40.29 | 29.24 | 5.69 | - |
| Gross Profit | 48.28 | 35.89 | 6.31 | 0.18 |
| Selling, General & Admin | 83 | 54.96 | 24.22 | 33.5 |
| Research & Development | 33.87 | 26.18 | 17.94 | 31.43 |
| Operating Expenses | 116.88 | 81.14 | 42.16 | 64.92 |
| Operating Income | -68.59 | -45.25 | -35.85 | -64.74 |
| Interest Expense | - | - | - | -0.01 |
| Interest & Investment Income | 9.23 | 3.91 | 1.78 | 0.2 |
| Other Non Operating Income (Expenses) | -18.47 | -13.41 | -10.03 | 0.91 |
| EBT Excluding Unusual Items | -77.84 | -54.76 | -44.1 | -63.65 |
| Other Unusual Items | - | - | - | -1.1 |
| Pretax Income | -77.84 | -54.76 | -44.1 | -64.75 |
| Net Income | -77.84 | -54.76 | -44.1 | -64.75 |
| Net Income to Common | -77.84 | -54.76 | -44.1 | -64.75 |
| Shares Outstanding (Basic) | 31 | 6 | 5 | 5 |
| Shares Outstanding (Diluted) | 31 | 6 | 5 | 5 |
| Shares Change (YoY) | 401.81% | 20.01% | 6.13% | - |
| EPS (Basic) | -2.50 | -8.60 | -8.31 | -12.96 |
| EPS (Diluted) | -2.50 | -8.60 | -8.31 | -12.96 |
| Free Cash Flow | -60.53 | -51.67 | -32.85 | -60.98 |
| Free Cash Flow Per Share | -1.94 | -8.12 | -6.19 | -12.20 |
| Gross Margin | 54.51% | 55.11% | 52.59% | 100.00% |
| Operating Margin | -77.45% | -69.48% | -298.88% | -36169.83% |
| Profit Margin | -87.89% | -84.08% | -367.64% | -36173.74% |
| Free Cash Flow Margin | -68.34% | -79.34% | -273.84% | -34067.04% |
| EBITDA | -67.33 | -44.1 | -34.62 | -63.4 |
| EBITDA Margin | -76.02% | -67.72% | -288.65% | - |
| D&A For EBITDA | 1.27 | 1.15 | 1.23 | 1.35 |
| EBIT | -68.59 | -45.25 | -35.85 | -64.74 |
| EBIT Margin | -77.45% | -69.48% | -298.87% | - |
| Revenue as Reported | - | - | - | 0.18 |
Source: S&P Capital IQ. Standard template.
Financial Sources.